OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Synthesis, Cytotoxic Evaluation, and Structure-Activity Relationship of Substituted Quinazolinones as Cyclin-Dependent Kinase 9 Inhibitors
Hamad M. Alkahtani, Amer Alhaj Zen, Ahmad J. Obaidullah, et al.
Molecules (2022) Vol. 28, Iss. 1, pp. 120-120
Open Access | Times Cited: 5
Hamad M. Alkahtani, Amer Alhaj Zen, Ahmad J. Obaidullah, et al.
Molecules (2022) Vol. 28, Iss. 1, pp. 120-120
Open Access | Times Cited: 5
Showing 5 citing articles:
S-Alkylated quinazolin-4(3H)-ones as dual EGFR/VEGFR-2 kinases inhibitors: design, synthesis, anticancer evaluation and docking study
Samar S. Tawfik, Abdelrahman Hamdi, Ahmed R. Ali, et al.
RSC Advances (2024) Vol. 14, Iss. 36, pp. 26325-26339
Open Access | Times Cited: 5
Samar S. Tawfik, Abdelrahman Hamdi, Ahmed R. Ali, et al.
RSC Advances (2024) Vol. 14, Iss. 36, pp. 26325-26339
Open Access | Times Cited: 5
Targeting Transcriptional CDKs 7, 8, and 9 with Anilinopyrimidine Derivatives as Anticancer Agents: Design, Synthesis, Biological Evaluation and In Silico Studies
Razan Eskandrani, Lamees S. Al-Rasheed, Siddique Akber Ansari, et al.
Molecules (2023) Vol. 28, Iss. 11, pp. 4271-4271
Open Access | Times Cited: 7
Razan Eskandrani, Lamees S. Al-Rasheed, Siddique Akber Ansari, et al.
Molecules (2023) Vol. 28, Iss. 11, pp. 4271-4271
Open Access | Times Cited: 7
Design, synthesis, and carbonic anhydrase inhibition activities of Schiff bases incorporating benzenesulfonamide scaffold: Molecular docking application
Adel S. El‐Azab, Alaa A.‐M. Abdel‐Aziz, Silvia Bua, et al.
Saudi Pharmaceutical Journal (2023) Vol. 31, Iss. 12, pp. 101866-101866
Open Access | Times Cited: 7
Adel S. El‐Azab, Alaa A.‐M. Abdel‐Aziz, Silvia Bua, et al.
Saudi Pharmaceutical Journal (2023) Vol. 31, Iss. 12, pp. 101866-101866
Open Access | Times Cited: 7
A multitier virtual screening of antagonists targeting PD-1/PD-L1 interface for the management of triple-negative breast cancer
HemaNandini Rajendran Krishnamoorthy, K. Ramanathan
Medical Oncology (2023) Vol. 40, Iss. 11
Closed Access | Times Cited: 4
HemaNandini Rajendran Krishnamoorthy, K. Ramanathan
Medical Oncology (2023) Vol. 40, Iss. 11
Closed Access | Times Cited: 4
Halogen‐based quinazolin‐4(3H)‐one derivatives as MCF‐7 breast cancer inhibitors: Current developments and structure–activity relationship
Rachana Upadhyay, P. K. Tandel, Amit B. Patel
Archiv der Pharmazie (2024) Vol. 358, Iss. 1
Closed Access
Rachana Upadhyay, P. K. Tandel, Amit B. Patel
Archiv der Pharmazie (2024) Vol. 358, Iss. 1
Closed Access
